NIH VideoCast - Foxp3, TSLP, and the Regulation of Immunity and Inflammation

Skip Navigation

Foxp3, TSLP, and the Regulation of Immunity and Inflammation

Loading... Loading video...

Air date:	Wednesday, September 30, 2009, 4:15:00 PM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 162 * This only includes stats from October 2011 and forward.
Category:	Immunology
Runtime:	01:10:41
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	Dr. Steven Ziegler is Director of the Immunology Program at Benaroya Research Institute. He graduated with honors from the University of Michigan in 1979, and in 1984 received his Ph.D. in Molecular Biology from UCLA. Following post-doctoral training at the University of Washington, Dr. Ziegler spent five years as a staff scientist at Immunex, followed by three years as the Director of Immunology/Molecular Biology at Darwin Molecular. He joined the Benaroya Research Institute at Virginia Mason in 1997, where he is now a Full Member and the Director of the Immunology Program. He is a leading authority on the role of FoxP3 in the control of CD4+CD25+ regulatory T cell and Th17 cell development and function. His group has also been investigating the role of thymic stromal lymphopoietin in the development of Th2-type immunity. His group showed that TSLP responses are absolutely required for the development of Th2-type allergic inflammation in mice. His current studies are focused on deciphering the regulation of TSLP gene expression, signal transduction from the TSLP receptor, and the identification and characterization of downstream mediators of TSLP-mediated inflammation. His group is also developing novel transgenic and knockout mice to understand the role of TSLP in respiratory virus infection. Steve is an excellent and highly entertaining speaker; so don't miss his exciting talk. The Immunology Interest Group

NLM Title:	Foxp3, TSLP, and the regulation of immunity and inflammation / Steven F. Ziegler, Director, Immunology Program, Benaroya Research Institute.
Author:	Ziegler, Steven Frank. National Institutes of Health (U.S.). Immunology Interest Group.
Publisher:
Abstract:	(CIT): Dr. Steven Ziegler is Director of the Immunology Program at Benaroya Research Institute. He graduated with honors from the University of Michigan in 1979, and in 1984 received his Ph.D. in Molecular Biology from UCLA. Following post-doctoral training at the University of Washington, Dr. Ziegler spent five years as a staff scientist at Immunex, followed by three years as the Director of Immunology/Molecular Biology at Darwin Molecular. He joined the Benaroya Research Institute at Virginia Mason in 1997, where he is now a Full Member and the Director of the Immunology Program. He is a leading authority on the role of FoxP3 in the control of CD4+CD25+ regulatory T cell and Th17 cell development and function. His group has also been investigating the role of thymic stromal lymphopoietin in the development of Th2-type immunity. His group showed that TSLP responses are absolutely required for the development of Th2-type allergic inflammation in mice. His current studies are focused on deciphering the regulation of TSLP gene expression, signal transduction from the TSLP receptor, and the identification and characterization of downstream mediators of TSLP-mediated inflammation. His group is also developing novel transgenic and knockout mice to understand the role of TSLP in respiratory virus infection. Steve is an excellent and highly entertaining speaker; so don't miss his exciting talk. The Immunology Interest Group.
Subjects:	Cytokines--immunology Forkhead Transcription Factors--immunology Inflammation--immunology Mutation--immunology Receptors, Cell Surface
Publication Types:	Lecture Webcast
NLM Classification:	QW 504.5
NLM ID:	101518943
CIT Live ID:	8081
Permanent link:	https://videocast.nih.gov/watch=8081

The server returned an invalid or unrecognized response